本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

20.06
-0.3200-1.57%
盤後20.060.00000.00%19:30 EDT
成交量:185.56萬
成交額:3,741.88萬
市值:32.07億
市盈率:-7.07
高:20.51
開:20.40
低:19.87
收:20.38
52周最高:27.30
52周最低:12.58
股本:1.60億
流通股本:1.51億
量比:1.29
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
淨資產收益率:-54.93%
總資產收益率:-29.15%
市淨率:3.84
市盈率(LYR):-6.75

資料載入中...

2020/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/29

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/01/27

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/01/16

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/14

重要事件披露

Current report, item 8.01
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/25

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/09/11

SEC問詢函

[Cover]Correspondence
2019/09/11

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/09/05

持股變動聲明

Statement of changes in beneficial ownership of securities